F13A Protein, Human, Recombinant (His)

Catalog Number: TGM-TMPJ-00535
Article Name: F13A Protein, Human, Recombinant (His)
Biozol Catalog Number: TGM-TMPJ-00535
Supplier Catalog Number: TMPJ-00535
Alternative Catalog Number: TGM-TMPJ-00535-1MG, TGM-TMPJ-00535-5UG, TGM-TMPJ-00535-10UG, TGM-TMPJ-00535-20UG, TGM-TMPJ-00535-50UG, TGM-TMPJ-00535-100UG, TGM-TMPJ-00535-200UG, TGM-TMPJ-00535-500UG
Manufacturer: TargetMol
Category: Biochemikalien
Alternative Names: F13A1 , Transglutaminase A Chain , F13A , Protein-Glutamine Gamma-Glutamyltransferase A Chain , Coagulation Factor XIIIa , Protein-Glutamine gamma-Glutamyltransferase A Chain , Coagulation Factor XIII A Chain
Coagulation factor XIII is the last zymogen to become activated in the blood coagulation cascade. Plasma factor XIII is a heterotetramer composed of 2 A subunits and 2 B subunits. The A subunits have catalytic function, and the B subunits do not have enzymatic activity and may serve as plasma carrier molecules. Platelet factor XIII is composed of just 2 A subunits, which are identical to those of plasma origin. Upon cleavage of the activation peptide by thrombin and in the presence of calcium ion, the plasma factor XIII dissociates its B subunits and yields the same active enzyme, factor XIIIa, as platelet factor XIII. This enzyme acts as a transglutaminase to catalyze the formation of gamma-glutamyl-epsilon-lysine crosslinking between fibrin molecules, thus stabilizing the fibrin clot. Factor XIII deficiency is classified into two categories: type I deficiency, characterized by the lack of both the A and B subunits, and type II deficiency, characterized by the lack of the A subunit alone. These defects can result in a lifelong bleeding tendency, defective wound healing, and habitual abortion.
Purity: 0.95